hemoglobinopathy

Search with Google Search with Bing
Information
Disease name
hemoglobinopathy
Disease ID
DOID:2860
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00001958 Completed Phase 2 Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia) December 1999 February 2002
NCT01200017 No longer available Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
NCT06313398 Recruiting Early Phase 1 Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling May 17, 2024 June 15, 2029
NCT00040417 Terminated Phase 2 Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies August 2000 November 21, 2003
NCT00040469 Terminated Phase 2 Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies August 2000 November 21, 2003
NCT00968864 Terminated Phase 2 T-cell Depleted Alternative Donor Transplantation August 2009 November 2016
Disase is a (Disease Ontology)
DOID:589
Cross Reference ID (Disease Ontology)
GARD:12455
Cross Reference ID (Disease Ontology)
ICD10CM:D58.2
Cross Reference ID (Disease Ontology)
MESH:D006453
Cross Reference ID (Disease Ontology)
NCI:C3092
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:154794008
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0019045
Exact Synonym (Disease Ontology)
hemoglobinopathies